Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
8.0
4.5
Journals
Cancers
Special Issues
Cancer Survivorship: During and after Treatment
share announcement

Cancer Survivorship: During and after Treatment

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Survivorship and Quality of Life".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 724

Special Issue Editor

Dr. Florian Scotte

E-Mail Website
Guest Editor
Patient Pathway Division, Gustave Roussy, 94805 Villejuif, France
Interests: cancer survivorship; treatment effects; quality of life; palliative care; cancer management

Special Issue Information

Dear Colleagues,

This Special Issue explores the challenges and experiences faced by individuals during and after cancer treatment. It delves into topics such as survivorship care planning, rehabilitation, return to work, managing treatment side effects, psychological support and lifestyle interventions to improve the quality of life post-treatment. The issue aims to provide insights into the unique needs of cancer survivors and highlight strategies for promoting long-term health and well-being beyond the treatment phase. Through a multidisciplinary approach, it offers valuable perspectives for healthcare professionals, researchers and survivors themselves navigating the journey of cancer survivorship.

Dr. Florian Scotte
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer survivorship
  • treatment effects
  • quality of life
  • palliative care
  • cancer management

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

16 pages, 1044 KiB  
Review
Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Narrative Review and Proposed Theoretical Model
by Kimberley T. Lee, Hailey W. Bulls, Aasha I. Hoogland, Brian W. James, Claudia B. Colon-Echevarria and Heather S. L. Jim
Cancers 2024, 16(14), 2571; https://doi.org/10.3390/cancers16142571 - 18 Jul 2024
Viewed by 589
Abstract
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating symptom experienced by cancer survivors. Despite the burden of CIPN-related symptoms, interventions remain limited. Objectives: This narrative review seeks to propose a framework for CIPN predisposing, precipitating, and perpetuating factors (3Ps), which will [...] Read more.
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating symptom experienced by cancer survivors. Despite the burden of CIPN-related symptoms, interventions remain limited. Objectives: This narrative review seeks to propose a framework for CIPN predisposing, precipitating, and perpetuating factors (3Ps), which will provide a foundation for future research and clinical interventions aimed at mitigating CIPN-related symptoms and morbidity. Methods: A comprehensive literature search was performed using PubMed, guided by keywords related to “chemotherapy-induced peripheral neuropathy.” Studies were limited to those with full text available in English. Results: Predisposing factors outlined in this framework, such as older age and comorbid conditions, can be used to identify patients who have a higher risk of developing CIPN. The major precipitating factor of CIPN is the delivery of chemotherapy to peripheral nerves, which may be mitigated via cryotherapy or compression therapy during chemotherapy. Perpetuating factors can offer insight into psychological, cognitive, and behavioral modifications that could be treatment targets for CIPN management. Conclusion: The proposed 3P model can guide the development of effective interventions for CIPN by suggesting modifiable psychological and behavioral treatment targets that may mitigate the impact of CIPN for cancer patients. Full article
(This article belongs to the Special Issue Cancer Survivorship: During and after Treatment)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop